IL-6 inhibitors are therapeutic agents designed to block the action of IL-6, thereby alleviating inflammatory responses and reducing tissue damage. These inhibitors are crucial in treating autoimmune diseases like rheumatoid arthritis, where IL-6 levels are abnormally high. By understanding the histological changes induced by IL-6, researchers can better appreciate the therapeutic potential of IL-6 inhibitors.
